浏览全部资源
扫码关注微信
Published:15 December 2024,
Received:11 September 2024,
Revised:21 September 2024,
移动端阅览
重庆药学会,《医疗机构药学巡诊服务专家共识》编写组.医疗机构药学巡诊服务专家共识 Δ[J].中国药房,2024,35(23):2837-2843.
.Expert consensus on pharmaceutical active consultation service in medical institutions[J].ZHONGGUO YAOFANG,2024,35(23):2837-2843.
重庆药学会,《医疗机构药学巡诊服务专家共识》编写组.医疗机构药学巡诊服务专家共识 Δ[J].中国药房,2024,35(23):2837-2843. DOI: 10.6039/j.issn.1001-0408.2024.23.01.
.Expert consensus on pharmaceutical active consultation service in medical institutions[J].ZHONGGUO YAOFANG,2024,35(23):2837-2843. DOI: 10.6039/j.issn.1001-0408.2024.23.01.
目的
2
进一步规范医疗机构药学巡诊的执行、管理标准,为医疗机构提供高质量药学服务提供参考。
方法
2
由重庆药学会指导、重庆医科大学附属第三医院牵头,联合多个医疗机构的药学与医务管理专家成立专家组,就药学巡诊的基本要求、服务过程、质量控制与评价改进等重点内容进行研讨,最终由执笔编写组对意见进行整理、归纳、分析、反馈、修订,最终形成共识。结果与
结论
2
本共识对药学巡诊的基本要求、服务过程、质量控制与评价改进等重点内容进行了详细的阐述,为我国医疗机构开展药学巡诊提供了规范与标准,对提高医疗机构的药学服务能力具有重要意义。
OBJECTIVE
2
To further standardize the implementation and management standards of pharmaceutical active consultation in medical institutions and provide a reference for providing high-quality pharmaceutical services.
METHODS
2
Guided by the Chongqing Pharmaceutical Association and led by the Third Affiliated Hospital of Chongqing Medical University, a panel of experts consisting of pharmaceutical and medical management professionals from multiple medical institutions was established to discuss the basic requirements, service processes, quality control, and evaluation improvement of pharmaceutical active consultation. The drafting team then organized, summarized, analyzed and revised the opinions, and provided feedback to ultimately form a consensus.
RESULTS &CONCLUSIONS
2
This consensus provides a detailed exposition of the basic requirements, service processes, quality control, and evaluation improvement of pharmaceutical active consultation, offering standards for the implementation of pharmaceutical active consultation in medical institutions in China, which is of major implications for strengthening the pharmaceutical service capabilities of medical institutions.
药学巡诊药学服务临床药学专家共识
pharmaceutical active consultationpharmacy serviceclinical pharmacyexpert consensus
国务院办公厅.卫生健康委 教育部 财政部 人力资源社会保障部 医保局 药监局关于印发加强医疗机构药事管理促进合理用药的意见的通知:国卫医发〔2020〕2号[EB/OL].(2020-02-21)[2024-04-29]. https://www.gov.cn/gongbao/content/2020/content_5522549.htmhttps://www.gov.cn/gongbao/content/2020/content_5522549.htm.
General Office of the State Council. Notice of the Health Commission,the Ministry of Education,the Ministry of Finance,the Ministry of Human Resources and Social Security,the Medical Insurance Bureau and the Food and Drug Administration on printing and distributing opinions on strengthening pharmaceutical affairs management in medical institutions and promoting rational drug use[EB/OL].(2020-02-21)[2024-04-29].https://www.gov.cn/gongbao/content/2020/content_5522549.htmhttps://www.gov.cn/gongbao/content/2020/content_5522549.htm.
财务司. 关于印发全国医疗服务项目技术规范(2023年版)的通知:国卫财务发〔2023〕27号[EB/OL].(2023-09-28)[2024-04-29]. http://www.nhc.gov.cn/caiwusi/s7785t/202309/914aec9618944ee2b36621d33517e576.shtmlhttp://www.nhc.gov.cn/caiwusi/s7785t/202309/914aec9618944ee2b36621d33517e576.shtml.
Finance Division. Notification on printing and distributing national technical specifications for medical services (2023 edition)[EB/OL]. (2023-09-28)[2024-04-29]. http://www.nhc.gov.cn/caiwusi/s7785t/202309/914aec-9618944ee2b36621d33517e576.shtmlhttp://www.nhc.gov.cn/caiwusi/s7785t/202309/914aec-9618944ee2b36621d33517e576.shtml.
福建省医疗保障局. 福建省医疗保障局关于在省属公立医院试行药学服务收费政策的通知:闽医保〔2022〕49号[EB/OL].(2022-04-08)[2024-04-29]. https://ybj.fujian.gov.cn/zfxxgkzl/zc/xzgfxwj/xxyxgfxwjdyp/202306/t20230-616_6188012.htmhttps://ybj.fujian.gov.cn/zfxxgkzl/zc/xzgfxwj/xxyxgfxwjdyp/202306/t20230-616_6188012.htm.
Fujian Provincial Medical Security Bureau. Notice of Fujian Provincial Health Insurance Bureau on trial implementation of pharmaceutical service charge policy in provincial public hospitals[EB/OL]. (2022-04-08)[2024-04-29]. https://ybj.fujian.gov.cn/zfxxgkzl/zc/xzgfxwj/xxyxgfxwjdyp/202306/t20230616_6188012.htmhttps://ybj.fujian.gov.cn/zfxxgkzl/zc/xzgfxwj/xxyxgfxwjdyp/202306/t20230616_6188012.htm.
河北省医疗保障局,河北省卫生健康委员会. 河北省医疗保障局 河北省卫生健康委员会关于试行药学类医疗服务价格项目的通知:冀医保函〔2023〕108号[EB/OL].(2023-09-27)[2024-04-29]. http://ylbzj.hebei.gov.cn/content/3000http://ylbzj.hebei.gov.cn/content/3000.
Hebei Provincial Medical Security Bureau,Hebei Provincial Health Commission. Notice of Hebei Provincial Medical Security Bureau Hebei Provincial Health Commission on trial implementation of pharmaceutical medical service price items[EB/OL].(2023-09-27)[2024-04-29]. http://ylbzj.hebei.gov.cn/content/3000http://ylbzj.hebei.gov.cn/content/3000.
湖南省医疗保障局. 关于新增和修订药学类医疗服务价格项目的通知:湘医保发〔2023〕46号[EB/OL].(2023-10-09)[2024-04-29]. https://ybj.hunan.gov.cn/ybj/first113541/firstF/f3113607/202310/t20231009_31641865.htmlhttps://ybj.hunan.gov.cn/ybj/first113541/firstF/f3113607/202310/t20231009_31641865.html.
Hunan Provincial Medical Security Bureau. Notice on adding and revising the price items of pharmaceutical medical services[EB/OL].(2023-10-09)[2024-04-29]. https://ybj.hunan.gov.cn/ybj/first113541/firstF/f3113607/202310/t20231009_31641865.htmlhttps://ybj.hunan.gov.cn/ybj/first113541/firstF/f3113607/202310/t20231009_31641865.html.
重庆市医疗保障局. 重庆市医疗保障局关于完善药学类医疗服务价格项目的通知:渝医保发〔2023〕34号[EB/OL].(2023-12-15)[2024-04-29]. https://ylbzj.cq.gov.cn/zwgk_535/zfxxgkml/zcwj_291934/gfxwj/202312/t20231-220_12725785.htmlhttps://ylbzj.cq.gov.cn/zwgk_535/zfxxgkml/zcwj_291934/gfxwj/202312/t20231-220_12725785.html.
Chongqing Medical Security Bureau. Notice of Chongqing Medical Security Bureau on improving the price items of pharmaceutical medical services[EB/OL].(2023-12-15)[2024-04-29]. https://ylbzj.cq.gov.cn/zwgk_535/zfxxgkml/zcwj_291934/gfxwj/202312/t20231220_12725785.htmlhttps://ylbzj.cq.gov.cn/zwgk_535/zfxxgkml/zcwj_291934/gfxwj/202312/t20231220_12725785.html.
江西省医疗保障局,江西省卫生健康委员会. 江西省医疗保障局 江西省卫生健康委员会关于新增和修订部分药学类医疗服务价格项目的通知:赣医保字〔2023〕43号[EB/OL].(2023-12-25)[2024-04-29]. http://www.jiangxi.gov.cn/art/2023/12/25/art_21221_4741453.htmlhttp://www.jiangxi.gov.cn/art/2023/12/25/art_21221_4741453.html.
Jiangxi Provincial Medical Security Bureau,Jiangxi Provincial Health Commission. Notice of Jiangxi Provincial Medical Security Bureau Jiangxi Provincial and Health Commission on adding and revising some pharmaceutical medical service price items[EB/OL].(2023-12-25)[2024-04-29]. http://www.jiangxi.gov.cn/art/2023/12/25/art_21221_4741453.htmlhttp://www.jiangxi.gov.cn/art/2023/12/25/art_21221_4741453.html.
湖北省医疗保障局,湖北省卫生健康委员会.省医疗保障局 省卫生健康委员会关于进一步做好药学类医疗服务价格项目管理有关事项的通知:鄂医保发〔2024〕4号[EB/OL].(2024-02-19)[2024-04-29]. http://wjw.hubei.gov.cn/zfxxgk/fdzdgknr/czzj/xzsysf/202402/t20240223_5093990.shtmlhttp://wjw.hubei.gov.cn/zfxxgk/fdzdgknr/czzj/xzsysf/202402/t20240223_5093990.shtml.
Hubei Provincial Medical Security Bureau,Hubei Provincial Health Commission.Notice of the Provincial Medical Security Bureau the Provincial Heath Commission on further improving the management of price items of pharmaceutical medical services[EB/OL].(2024-02-19)[2024-04-29]. http://wjw.hubei.gov.cn/zfxxgk/fdzdgknr/czzj/xzsysf/202402/t20240223_5093990.shtmlhttp://wjw.hubei.gov.cn/zfxxgk/fdzdgknr/czzj/xzsysf/202402/t20240223_5093990.shtml.
山东省医疗保障局.山东省医疗保障局关于新增药学类医疗服务项目价格的通知:鲁医保发〔2024〕10号[EB/OL].(2024-04-29)[2024-06-15]. http://www.shandong.gov.cn/art/2024/4/29/art_100619_44631.htmlhttp://www.shandong.gov.cn/art/2024/4/29/art_100619_44631.html.
Shandong Provincial Medical Security Bureau. Notice of Shandong Provincial Medical Security Bureau on the price of new pharmaceutical medical services[EB/OL].(2024-04-29)[2024-06-15]. http://www.shandong.gov.cn/art/2024/4/29/art_100619_44631.htmlhttp://www.shandong.gov.cn/art/2024/4/29/art_100619_44631.html.
郑大喜,罗 毅. 药学类医疗服务价格政策回顾、项目设立与启示[J/OL].中国卫生经济,2024,43(8):41-46[2024-09-04]. http://kns.cnki.net/kcms/detail/23.1042.f.20240709.1755.022.htmlhttp://kns.cnki.net/kcms/detail/23.1042.f.20240709.1755.022.html.
ZHENG D X,LUO Y. Policy review,items establishment and enlightenment of pharmaceutical medical service price[J/OL]. Chin Health Econ,2024,43(8):41-46[2024-09-04]. http://kns.cnki.net/kcms/detail/23.1042.f.20240709.1755.022.htmlhttp://kns.cnki.net/kcms/detail/23.1042.f.20240709.1755.022.html.
李琴,范国荣. 建立临床药师驻科工作制,探索药学服务新标杆[J].上海医药,2023,44(23):23-29.
LI Q,FAN G R. Establishing a clinical pharmacist residency work system,exploring a new benchmark for pharmaceutical services[J]. Shanghai Med Pharm J,2023,44(23):23-29.
蒋君好,郑航,严波. 临床药师队伍的现状、问题与建设措施[J]. 中国高等医学教育,2024(3):32-33,36.
JIANG J H,ZHENG H,YAN B. Current status,issues,and measures for the construction of clinical pharmacist teams[J]. China High Med Educ,2024(3):32-33,36.
边江瑜婧,顾红燕,陆浩,等.国际药学实践研究进展及对我国药学服务高质量发展的启示[J].中国药学杂志,2024,59(5):457-462.
BIAN J Y J,GU H Y,LU H,et al. Advances in international pharmaceutical practice research and implications for the high-quality development of pharmaceutical care in China[J]. Chin Pharm J,2024,59(5):457-462.
杨玉霞,陈宁. 我国临床药学服务发展存在的问题及对策建议[J]. 临床合理用药,2024,17(5):159-162.
YANG Y X,CHEN N. Problems and countermeasures in the development of clinical pharmaceutical services in China[J]. Chin J Clin Ration Drug Use,2024,17(5):159-162.
杜倩,奚鑫,董杰,等. 药学巡诊:一种新型医院药学服务模式[J]. 中国药房,2022,33(21):2666-2670,2675.
DU Q,XI X,DONG J,et al. Pharmacy active consultation:an innovative model of hospital pharmaceutical services[J]. China Pharm,2022,33(21):2666-2670,2675.
DU Q,XI X,DONG J,et al. The impact of pharmacist early active consultation (PEAC) on multidrug resistance organism treatment outcomes:a prospective historically controlled study[J]. Front Pharmacol,2023,14:1128219.
LI D X,DONG J,XI X,et al. Impact of pharmacist active consultation on clinical outcomes and quality of medical care in drug-induced liver injury inpatients in general ho- spital wards:a retrospective cohort study[J]. Front Pharmacol,2022,13:972800.
国家卫生健康委员会.医疗质量管理办法[EB/OL].(2016-10-12)[2024-04-29]. http://www.nhc.gov.cn/yzygj/s3585/201610/5b61766ab433435fab6d5111c138d9f9.shtmlhttp://www.nhc.gov.cn/yzygj/s3585/201610/5b61766ab433435fab6d5111c138d9f9.shtml.
National Health Commission. Measures for the administration of medical quality[EB/OL].(2016-10-12)[2024-04-29]. http://www.nhc.gov.cn/yzygj/s3585/201610/5b617- 66ab433435fab6d5111c138d9f9.shtmlhttp://www.nhc.gov.cn/yzygj/s3585/201610/5b617-66ab433435fab6d5111c138d9f9.shtml.
国家卫生健康委员会.卫生部 国家中医药管理局 总后勤部卫生部关于印发《医疗机构药事管理规定》的通知:卫医政发〔2011〕11号[EB/OL]. (2011-03-30)[2024-04-29]. http://www.nhc.gov.cn/wjw/gfxwj/201304/0149-ba1f66bd483995bb0ea51a354de1.shtmlhttp://www.nhc.gov.cn/wjw/gfxwj/201304/0149-ba1f66bd483995bb0ea51a354de1.shtml.
National Health Commission. Notice of the Ministry of Health, State Administration of Traditional Chinese Medicine, General Logistics Department of the Ministry of Health on printing and distributing the Provisions on the Administration of Pharmaceutical Affairs in Medical Institutions[EB/OL]. (2011-03-30)[2024-04-29]. http://www.nhc.gov.cn/wjw/gfxwj/201304/0149ba1f66bd483995bb0ea-51a354de1.shtmlhttp://www.nhc.gov.cn/wjw/gfxwj/201304/0149ba1f66bd483995bb0ea-51a354de1.shtml.
国家卫生健康委员会.医疗质量安全核心制度要点:国卫医发〔2018〕8号[EB/OL].(2018-04-21)[2024-04-29]. http://www.nhc.gov.cn/yzygj/s3585/201804/aeafaa4fab- 304bdd88a651dab5a4553d.shtmlhttp://www.nhc.gov.cn/yzygj/s3585/201804/aeafaa4fab-304bdd88a651dab5a4553d.shtml.
National Health Commission. Key points of medical qua- lity and safety core system[EB/OL].(2018-04-21)[2024-04-29]. http://www.nhc.gov.cn/yzygj/s3585/201804/aeafaa4fab304bdd88a651dab5a4553d.shtmlhttp://www.nhc.gov.cn/yzygj/s3585/201804/aeafaa4fab304bdd88a651dab5a4553d.shtml.
国家卫生健康委员会.卫生部关于印发《病历书写基本规范》的通知:卫医政发〔2010〕11号[EB/OL].(2010-01-23)[2024-04-29].http://www.nhc.gov.cn/wjw/gfxwj/201304/1917f257cd774afa835cff168dc4ea41.shtmlhttp://www.nhc.gov.cn/wjw/gfxwj/201304/1917f257cd774afa835cff168dc4ea41.shtml.
National Health Commission. Notice of the Ministry of Health on printing and distributing the Basic Norms of Medical Record Writing[EB/OL].(2010-01-23)[2024-04-29]. http://www.nhc.gov.cn/wjw/gfxwj/201304/1917f257-cd774afa835cff168dc4ea41.shtmlhttp://www.nhc.gov.cn/wjw/gfxwj/201304/1917f257-cd774afa835cff168dc4ea41.shtml.
中国医院协会.中国医院协会关于发布《医疗机构药事管理与药学服务》九项团体标准的通知[EB/OL]. (2022-12-30)[2024-04-29]. https://www.cha.org.cn/site/content/a1fa2d1bd90bd19ae2dfa0bc027fbef9.htmlhttps://www.cha.org.cn/site/content/a1fa2d1bd90bd19ae2dfa0bc027fbef9.html.
China Hospital Association. Notice of China Hospital Association on issuing nine group standards of Pharmaceutical Affairs Management and Pharmaceutical Services in Medical Institutions[EB/OL].(2022-12-30)[2024-04-29]. https://www.cha.org.cn/site/content/a1fa2d1bd9-0bd19ae2dfa0bc027fbef9.htmlhttps://www.cha.org.cn/site/content/a1fa2d1bd9-0bd19ae2dfa0bc027fbef9.html.
0
Views
238
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution